Skip to main content

Nasacort AQ Nasal Spray (Triamcinolone Acetonide) Shopper Approved

Prescription Prescription Required FormationFormulation: Nasal spray

Nasacort AQ Nasal Spray

(Brand Option)

Select the prescribed dosage

Select the quantity to see the price.

  *  
Prescription Prescription Required FormationFormulation: Nasal spray

Triamcinolone Acetonide

We don't sell this generic-version medication.

Select the quantity to see the price.

  *  
delivery

* This price includes a dispensing fee, medical review fee, and packing fee.

delivery

Shipped and delivered directly to your doorstep

Nasacort AQ Nasal Spray is a medication used to relieve nasal allergy symptoms, including congestion, sneezing, a runny nose, and itching.

It contains triamcinolone acetonide, an active ingredient that helps reduce inflammation in the nasal passages caused by allergic reactions.

Nasacort AQ belongs to a class of medications called intranasal corticosteroids. These medications work by reducing inflammation and controlling the local immune response responsible for nasal allergy symptoms.

When a person is exposed to allergens such as pollen, dust mites, pet dander, or mold, the immune system may release substances that cause swelling and irritation inside the nose.

This inflammation can lead to nasal congestion, frequent sneezing, excessive mucus production, and itching.

Nasacort AQ helps reduce these symptoms by calming inflammation in the nasal passages.

It is used to manage both seasonal and perennial allergic rhinitis, which are common forms of nasal allergies.

Nasacort AQ helps control nasal allergy symptoms, but it does not permanently cure allergies or eliminate sensitivity to allergens.

Treatment of Seasonal Allergic Rhinitis

Nasacort AQ is used to relieve symptoms of seasonal allergic rhinitis, commonly known as hay fever.

Seasonal allergic rhinitis occurs when the immune system reacts to allergens that are more common during particular times of the year.

These allergens often include tree pollen, grass pollen, and weed pollen.

When these particles enter the nose, the immune system may trigger an inflammatory response.

This can cause swelling of the nasal lining and increased mucus production.

Common symptoms of seasonal allergic rhinitis include nasal congestion, sneezing, a runny nose, and itching inside the nose.

Some patients may also experience watery or irritated eyes, postnasal drip, or difficulty sleeping because of nasal discomfort.

Nasacort AQ helps reduce inflammation caused by exposure to seasonal allergens.

With regular use, the medication may improve nasal breathing and reduce the frequency and severity of allergy symptoms.

Patients who experience predictable seasonal allergies may benefit from starting treatment before their usual allergy season, as recommended by their healthcare provider.

Nasacort AQ helps relieve seasonal nasal allergy symptoms by reducing inflammation caused by pollen and other seasonal allergens.

Treatment of Perennial Allergic Rhinitis

Nasacort AQ is also used to treat perennial allergic rhinitis.

Perennial allergic rhinitis is a type of nasal allergy that can occur throughout the year rather than during a particular season.

It is commonly triggered by allergens found in homes, workplaces, or other indoor environments.

Common triggers include dust mites, pet dander, indoor mold, and cockroach allergens.

Because these allergens may be present year-round, some patients experience persistent or recurring symptoms.

Symptoms may include ongoing nasal congestion, frequent sneezing, a runny nose, and itching.

Chronic nasal congestion may also interfere with sleep, concentration, and everyday activities.

Nasacort AQ helps reduce the inflammation responsible for these symptoms.

Regular treatment may improve nasal airflow and help patients manage their allergies more comfortably.

However, reducing exposure to identified allergens remains an important part of allergy management.

Nasacort AQ helps control year-round nasal allergy symptoms, particularly congestion, sneezing, and a runny or itchy nose.

How Does Nasacort AQ Nasal Spray Work?

Nasacort AQ contains triamcinolone acetonide, a corticosteroid that helps control inflammation inside the nose.

When allergens enter the nasal passages, the immune system may release substances that trigger inflammation.

These substances cause the blood vessels and tissues inside the nose to become swollen and irritated.

As a result, patients may experience nasal congestion, itching, sneezing, and increased mucus production.

Nasacort AQ helps reduce this inflammatory response, allowing the nasal passages to become less swollen and irritated.

Reduces Nasal Inflammation

Nasacort AQ decreases the activity of inflammatory substances involved in allergic reactions.

This helps reduce swelling and irritation in the nasal lining.

Relieves Nasal Congestion

Inflammation can cause the tissues inside the nose to swell, making breathing through the nose more difficult.

By reducing swelling, Nasacort AQ may improve nasal airflow and relieve the blocked or stuffy feeling associated with allergies.

Controls Sneezing and a Runny Nose

Allergic reactions can stimulate increased mucus production and irritate sensitive tissues in the nose.

Nasacort AQ helps control these symptoms by reducing the underlying inflammation.

Helps Prevent Recurring Allergy Symptoms

When used consistently, Nasacort AQ can help maintain control of nasal allergy symptoms during periods of allergen exposure.

Unlike fast-acting nasal decongestants, it does not provide immediate relief by directly constricting blood vessels.

Nasacort AQ works by reducing inflammation in the nasal passages, helping relieve congestion, sneezing, itching, and a runny nose. 

How Long Does Nasacort AQ Take to Work?

Nasacort AQ does not usually provide immediate relief after the first application.

Some patients may notice improvement during the first day, but meaningful symptom relief often takes two to three days of regular treatment.

For others, it may take up to two weeks to experience the full benefit.

The time needed for improvement depends on symptom severity, the level of allergen exposure, and the individual’s response to treatment.

Using the nasal spray consistently is important because corticosteroids work by gradually reducing inflammation.

For seasonal allergies, your healthcare provider may recommend starting Nasacort AQ before the expected allergy season.

Use Nasacort AQ regularly as directed, even if your symptoms do not improve immediately. 

Important Information About Nasacort AQ Nasal Spray

Nasacort AQ is an aqueous nasal spray containing 55 micrograms of triamcinolone acetonide per metered spray.

It is intended for use inside the nose only and should not be sprayed into the eyes or mouth.

The appropriate dosage depends on the patient’s age, symptoms, and product-specific instructions.

In Canada, prescription Nasacort AQ is indicated for children aged 4 to 12 years whose seasonal or perennial allergic rhinitis has not responded adequately to conventional treatment. The separate Nasacort Allergy 24HR product is authorized for adults and children aged 12 years and older.

Possible side effects include nasal irritation, dryness, sneezing, headache, and nosebleeds.

Patients who have recently undergone nasal surgery or experienced a nasal injury should consult their healthcare provider before use.

Regular follow-up may be needed for patients requiring prolonged treatment, particularly children, because nasal corticosteroids may affect growth.

Nasacort AQ helps manage nasal allergy symptoms when used correctly and consistently. Follow the instructions for your specific product and consult your healthcare provider if symptoms persist, worsen, or are accompanied by frequent nosebleeds. 

Nasacort AQ Nasal Spray is a medication used to relieve nasal allergy symptoms, including congestion, sneezing, a runny nose, and itching.

It contains triamcinolone acetonide, a corticosteroid that helps reduce inflammation and swelling inside the nasal passages.

Nasacort AQ is administered directly into the nose using a metered-dose spray device. Each spray delivers a measured amount of medication to help control symptoms of seasonal or year-round allergic rhinitis.

The recommended dosage depends on the patient’s age, medical condition, response to treatment, and the specific Nasacort product being used.

For many triamcinolone nasal spray products, the usual adult starting dosage is two sprays in each nostril once daily, delivering a total of 220 micrograms per day. The dosage may be reduced once symptoms are adequately controlled.

However, product-specific dosing and approved age ranges differ by country. In Canada, prescription Nasacort AQ has specific pediatric indications, while other Nasacort formulations have different instructions.

Younger children may require a lower dosage and assistance from a parent or caregiver.

Before using Nasacort AQ, gently blow your nose to clear the nasal passages and make sure the spray device has been properly primed.

Use Nasacort AQ exactly as directed by your healthcare provider. Do not increase the number of sprays or use the medication more frequently than prescribed.

How to Use Nasacort AQ Nasal Spray Correctly

Nasacort AQ should be sprayed directly into the nostrils according to the instructions supplied with your medication.

Correct administration helps deliver the medication to the nasal lining while reducing irritation and unnecessary exposure to other areas.

To use Nasacort AQ:

  1. Prepare Your Nose: Gently blow your nose to remove excess mucus and help clear the nasal passages.
  2. Remove the Protective Cap: Take off the cap covering the spray nozzle. Check that the nozzle is clean and unobstructed.
  3. Prime the Spray if Necessary: If the device is new or has not been used for a period specified in the package instructions, prime it before administration.
  4. Position Your Head: Keep your head upright or tilt it slightly forward, following the instructions supplied with your product.
  5. Close One Nostril: Gently press one nostril closed with your finger.
  6. Insert the Spray Nozzle: Place the nozzle into the open nostril, pointing it slightly outward, away from the nasal septum. The septum is the wall separating the nostrils.
  7. Administer the Medication: Press the spray device firmly while breathing in gently through your nose. Avoid sniffing forcefully.
  8. Breathe Out: Exhale gently through your mouth.
  9. Repeat if Necessary: If another spray is prescribed, administer it according to the product instructions.
  10. Treat the Other Nostril: Repeat the process in the opposite nostril.
  11. Replace the Cap: Wipe the nozzle if necessary and replace the protective cap after use.

Try to avoid blowing your nose for approximately 15 minutes after administration so the medication can remain in contact with the nasal lining.

Do not spray the medication directly onto the nasal septum because repeated irritation may increase the risk of nosebleeds.

For the best results, aim Nasacort AQ slightly outward toward the side of the nostril rather than directly toward the center of your nose.

What Is the Recommended Dosage of Nasacort AQ?

The dosage of Nasacort AQ depends on the patient’s age, severity of allergy symptoms, and response to treatment.

Nasacort AQ contains 55 micrograms of triamcinolone acetonide per metered spray.

For many adult formulations, the recommended starting dose is two sprays in each nostril once daily.

Once allergy symptoms are adequately controlled, the dosage may be reduced to one spray in each nostril once daily.

Children may require a lower dosage, depending on their age and the specific product instructions.

Some pediatric regimens begin with one spray in each nostril once daily and may be adjusted by the prescribing healthcare provider.

It is important to follow the dosing instructions for your particular product because approved ages and dosage schedules differ between formulations.

Taking more medication than recommended does not necessarily provide better allergy relief and may increase the risk of side effects.

Always follow the dosage printed on your prescription label or recommended by your healthcare provider. Do not adjust the number of daily sprays without medical advice.

How to Prime Nasacort AQ Nasal Spray

Priming prepares the spray device so it can deliver the correct amount of medication.

A new Nasacort AQ bottle must be primed before its first use.

To prime the spray:

  1. Remove the protective cap.
  2. Shake the bottle gently if instructed by your product’s package directions.
  3. Hold the bottle upright with the nozzle pointing away from your face.
  4. Press the spray pump repeatedly until a fine mist appears.
  5. Once the spray produces a consistent mist, it is ready to use.

Many Nasacort AQ devices require approximately five pump activations for initial priming.

If the device has not been used for more than two weeks, it may need to be reprimed with a single spray, depending on the manufacturer’s instructions.

Do not prime the spray directly into your nose, eyes, or toward another person.

Follow the priming instructions supplied with your specific Nasacort AQ device to ensure that each dose is delivered correctly.

Use of Nasacort AQ in Children

Children may use certain Nasacort AQ formulations when treatment is appropriate for their age and symptoms.

However, the recommended dosage and approved age range differ between countries and products.

Children generally require lower doses than adults because of differences in body size and sensitivity to corticosteroids.

A parent or caregiver may need to help younger children administer the medication correctly.

Children should be encouraged to breathe gently through the nose while the spray is administered.

Avoid directing the spray toward the center of the nose, as this may irritate the nasal septum.

Long-term use of nasal corticosteroids may affect growth in some children, even when there are no other obvious side effects.

For this reason, a healthcare provider may recommend monitoring the child’s growth during prolonged treatment.

Use Nasacort AQ in children only according to the age restrictions and dosage instructions for the prescribed product. 

Why Is It Important to Use Nasacort AQ Regularly?

Nasacort AQ works by gradually reducing inflammation inside the nasal passages.

Unlike some nasal decongestants, it is not designed to provide immediate relief from congestion.

Some patients may notice improvements within the first day of treatment, while others may require several days of consistent use.

The full benefit may take up to a week or longer.

Using Nasacort AQ regularly helps maintain control of nasal allergy symptoms, particularly during ongoing exposure to allergens.

For seasonal allergies, your healthcare provider may recommend starting treatment before the usual allergy season.

Try to administer the spray at approximately the same time each day.

Use Nasacort AQ consistently according to your prescribed schedule, even if relief is not immediate.

How to Clean a Blocked Nasacort AQ Spray Nozzle

The spray nozzle should be kept clean to maintain proper medication delivery.

If the nozzle becomes blocked, the spray may produce an uneven mist or fail to deliver medication correctly.

Follow the cleaning procedure provided with your specific Nasacort AQ package.

Generally, this involves removing the cap and spray nozzle, when the device is designed to permit removal, and rinsing them with warm water.

Allow the components to dry before reassembling the device.

Do not use needles, pins, or other sharp objects to clear the opening.

Inserting objects into the nozzle may damage the spray mechanism and affect the accuracy of the delivered dose.

After cleaning, prime the device again if required by the manufacturer’s instructions.

Never use a sharp object to unblock the nozzle. Follow the manufacturer’s cleaning instructions to ensure the device continues delivering accurate doses.

How Many Sprays Are in a Nasacort AQ Bottle?

The number of sprays available depends on the product and bottle size.

Certain prescription Nasacort AQ bottles provide 120 metered sprays after the device has been properly primed.

Each metered spray delivers 55 micrograms of triamcinolone acetonide.

It is important to keep track of the number of sprays used.

Once the labelled number of sprays has been reached, the device may no longer deliver an accurate amount of medication.

Even if liquid remains inside the bottle, the medication may not be dispensed at the correct dose.

Canadian prescription Nasacort AQ instructions also specify discarding the bottle after 120 sprays or two months after starting treatment, whichever occurs first.

Do not transfer any remaining liquid into another spray bottle.

Discard Nasacort AQ according to the spray count and time limits stated on your product packaging, even if the bottle still contains liquid. 

What Should I Do If I Miss a Dose of Nasacort AQ?

If you forget to use Nasacort AQ, administer the missed dose when you remember, unless it is almost time for your next scheduled dose.

If your next dose is approaching, skip the missed dose and continue with your regular schedule.

Do not use additional sprays to make up for a missed dose.

Using more medication than recommended may increase the risk of side effects without providing additional allergy relief.

If you frequently forget your medication, consider setting a daily reminder.

Never double your Nasacort AQ dose to make up for a missed application.

Important Precautions When Using Nasacort AQ

Nasacort AQ is intended for use inside the nose only.

Avoid spraying the medication into your eyes or mouth. If it accidentally enters your eyes, rinse them thoroughly with water.

Possible side effects include nasal dryness, irritation, sneezing, headache, and nosebleeds.

Tell your healthcare provider if you experience frequent nosebleeds, persistent nasal discomfort, or changes in vision.

Patients who have recently undergone nasal surgery or experienced a nasal injury should consult their healthcare provider before using Nasacort AQ because corticosteroids may delay wound healing.

Do not share your nasal spray with another person, as this may spread infections.

Use Nasacort AQ only at the prescribed dosage, follow the correct administration technique, and contact your healthcare provider if your symptoms persist or worsen.

Common Side Effects of Nasacort AQ Nasal Spray (Triamcinolone Acetonide):

  • Mild stinging or burning in your nose
  • Sneezing after use of the medicine

Serious Side Effects of Nasacort AQ Nasal Spray (Triamcinolone Acetonide):

  • Blurry vision
  • Body aches
  • Chills
  • Eye pain
  • Fever
  • Flu symptoms
  • Nosebleeds
  • Seeing halos around lights
  • Tunnel vision

Nasacort AQ Nasal Spray (Triamcinolone Acetonide) is available in the following forms and strength:

Nasacort AQ Nasal Spray: Nasal Spray

  • 55 ug

Nasal Infections and Recent Sinus Surgery

Nasacort AQ should be used with caution in patients who have an active nasal infection, recently undergone nasal surgery, or experienced an injury inside the nose.

Nasacort AQ contains triamcinolone acetonide, a corticosteroid that reduces inflammation in the nasal passages.

Although this helps relieve allergy symptoms, corticosteroids can also affect the body’s local immune response and slow tissue healing.

Patients with untreated infections involving the nasal passages may experience worsening symptoms or delayed recovery.

Possible signs of a nasal infection include persistent nasal discharge, facial pain, swelling, fever, or worsening congestion.

Some infections, particularly fungal infections, require specific treatment before a nasal corticosteroid can be used safely.

Patients who have recently undergone sinus surgery or experienced a nasal injury should also be cautious.

The tissues inside the nose need time to heal, and corticosteroids may interfere with this process.

Your healthcare provider will determine whether Nasacort AQ should be temporarily avoided until the infection has resolved or the affected tissues have healed.

Do not use Nasacort AQ on unhealed nasal wounds or after recent nasal surgery without your healthcare provider’s approval. Contact your healthcare provider if you develop signs of a nasal infection during treatment.

Liver and Kidney Problems

Tell your healthcare provider if you have liver disease, kidney disease, or reduced organ function before using Nasacort AQ.

The liver helps process many medications, including corticosteroids that enter the bloodstream.

Although Nasacort AQ is sprayed directly into the nose and generally produces relatively low systemic exposure, a portion of the medication may still be absorbed into the body.

Patients with significant liver impairment may process absorbed corticosteroids differently.

This could potentially increase systemic exposure, particularly with prolonged treatment or higher-than-recommended doses.

However, routine dosage adjustments for Nasacort AQ have not been established specifically for patients with liver or kidney disease.

Kidney impairment is also not generally considered a major contraindication to intranasal triamcinolone.

Your healthcare provider will review your medical history and determine whether additional monitoring is appropriate.

Tell your healthcare provider if you have significant liver or kidney disease before starting Nasacort AQ, particularly if you use other corticosteroid medications.

Tuberculosis and Other Infections

Nasacort AQ should be used cautiously in patients with tuberculosis or certain untreated infections.

Tuberculosis is a bacterial infection that most commonly affects the lungs but can also involve other parts of the body.

Corticosteroids reduce inflammation by modifying the immune response.

Although Nasacort AQ acts mainly inside the nose, corticosteroid exposure may affect the body’s ability to control certain infections.

Patients with active or previously untreated tuberculosis should discuss their condition with a healthcare provider before using the medication.

Additional caution may be necessary for patients with untreated fungal, bacterial, viral, or parasitic infections.

Your healthcare provider may recommend treating the underlying infection before starting Nasacort AQ.

Tell your healthcare provider if you have tuberculosis or another significant infection. Do not use Nasacort AQ to treat symptoms caused by an infection unless your healthcare provider determines that it is appropriate.

Herpes Infection of the Eyes

Patients with a history of ocular herpes simplex infection should inform their healthcare provider before using Nasacort AQ.

Ocular herpes is a viral infection that affects the eye and may involve the cornea, the clear surface covering the front of the eye.

Symptoms may include eye redness, pain, sensitivity to light, blurred vision, and excessive tearing.

Corticosteroids can influence the immune response and may worsen certain viral infections when used inappropriately.

Although Nasacort AQ is administered into the nose rather than directly into the eyes, patients with active or recurrent ocular herpes should receive individualized medical advice.

Your healthcare provider may consider the severity of your eye condition and whether additional monitoring is needed.

Do not spray Nasacort AQ directly into your eyes.

Tell your healthcare provider if you have a history of ocular herpes. Seek prompt medical attention if you develop eye pain, redness, sensitivity to light, or changes in vision.

Glaucoma and Cataracts

Nasacort AQ should be used with caution in patients with a history of glaucoma or cataracts.

Glaucoma is a group of eye conditions that can damage the optic nerve, which transmits visual information from the eyes to the brain.

Elevated pressure inside the eye is an important risk factor for many forms of glaucoma.

Cataracts occur when the normally clear lens of the eye becomes cloudy, resulting in blurred or reduced vision.

Long-term corticosteroid exposure has been associated with an increased risk of glaucoma and cataracts.

Although the risk associated with intranasal corticosteroids is generally lower than with systemic corticosteroids, eye-related complications have been reported.

Patients using Nasacort AQ for extended periods may require eye examinations, particularly if they have existing eye conditions.

Tell your healthcare provider if you experience blurred vision, eye pain, halos around lights, or other visual disturbances.

Inform your healthcare provider if you have glaucoma, cataracts, or elevated eye pressure. Seek medical evaluation if you notice new or worsening vision problems during Nasacort AQ treatment.

Using Nasacort AQ With Other Immunosuppressive Medications

Tell your healthcare provider if you take medications that suppress or modify the immune system.

Immunosuppressive medications reduce the activity of the immune system and are used to manage certain inflammatory, autoimmune, and other medical conditions.

Examples include oral corticosteroids such as prednisone, certain medications used after organ transplantation, and some treatments for autoimmune disorders.

Using multiple corticosteroid medications may increase overall corticosteroid exposure.

For example, patients may use an inhaled corticosteroid for asthma, a topical corticosteroid for eczema, and Nasacort AQ for nasal allergies.

Although each medication may be appropriate individually, combined exposure can increase the likelihood of certain side effects.

Patients receiving immunosuppressive treatments may also be more vulnerable to infections.

Your healthcare provider will review your medications and determine whether any changes or additional monitoring are needed.

Tell your healthcare provider about all corticosteroids and immunosuppressive medications you use. Do not stop prescribed treatments without medical guidance.

Exposure to Chickenpox, Measles, and Other Contagious Diseases

Patients using Nasacort AQ should take appropriate precautions to avoid exposure to certain contagious diseases, particularly if they are not immune or are also taking medications that suppress the immune system.

Corticosteroids can reduce immune system activity, which may make it more difficult for the body to respond to certain infections.

Chickenpox and measles are highly contagious viral illnesses that can cause serious complications in susceptible individuals.

Although Nasacort AQ generally produces less systemic corticosteroid exposure than oral corticosteroids, caution is still recommended, particularly with prolonged use or other immunosuppressive treatments.

Patients who have never had chickenpox or measles and have not been vaccinated may be at greater risk if exposed.

If you come into contact with someone who has chickenpox or measles, notify your healthcare provider promptly.

Your healthcare provider may assess your immunity and determine whether preventive treatment is necessary.

Tell your healthcare provider immediately if you are exposed to chickenpox or measles and are not immune. Seek medical advice if you develop a persistent fever or other signs of infection. 

Long-Term Use and Adrenal Gland Suppression

Nasacort AQ should be used at the lowest effective dose needed to control nasal allergy symptoms.

Although the medication acts mainly inside the nose, some triamcinolone may enter the bloodstream.

Using higher-than-recommended doses or taking multiple corticosteroid medications may increase the risk of systemic side effects.

One potential complication is adrenal suppression.

The adrenal glands are small organs located above the kidneys that produce hormones, including cortisol.

Cortisol helps regulate blood pressure, metabolism, stress responses, and several other essential body functions.

Prolonged exposure to excessive corticosteroid levels may reduce the body’s natural cortisol production.

This can affect the body’s ability to respond to physical stress, such as illness, injury, or surgery.

Possible symptoms of adrenal insufficiency include unusual fatigue, weakness, dizziness, nausea, and low blood pressure.

Adrenal suppression is uncommon with properly dosed intranasal corticosteroids but can occur in susceptible patients.

Your healthcare provider may recommend additional monitoring if you use Nasacort AQ at high doses or alongside other corticosteroids.

If adrenal suppression develops, treatment may need to be adjusted gradually under medical supervision.

Do not exceed your prescribed Nasacort AQ dosage. Contact your healthcare provider if you develop unusual weakness, persistent fatigue, severe dizziness, or other symptoms suggesting adrenal problems. 

Osteoporosis and Bone Health

Tell your healthcare provider if you have osteoporosis or other conditions that affect bone strength.

Osteoporosis occurs when bones lose density and become weaker, increasing the risk of fractures.

Long-term exposure to systemic corticosteroids can interfere with normal bone formation and increase bone breakdown.

However, Nasacort AQ is administered directly into the nose, and its effects on bone health are generally much smaller than those of oral corticosteroids.

Osteoporosis is not a common side effect of Nasacort AQ at recommended doses.

Nevertheless, patients who use multiple corticosteroid medications or require prolonged high-dose treatment may have increased systemic exposure.

Other risk factors for osteoporosis include older age, low calcium intake, vitamin D deficiency, smoking, and certain chronic medical conditions.

Your healthcare provider may evaluate your overall bone health if you have significant risk factors.

Maintaining adequate calcium and vitamin D intake, participating in appropriate weight-bearing exercise, and avoiding smoking may help support bone health.

Tell your healthcare provider if you have osteoporosis or take medications that weaken bones. Use Nasacort AQ only at the recommended dosage to minimize unnecessary corticosteroid exposure.

Diabetes and Blood Glucose Levels

Patients with diabetes should tell their healthcare provider before using Nasacort AQ.

Diabetes is a chronic condition that affects the body’s ability to regulate blood glucose, also called blood sugar.

Corticosteroids can influence glucose metabolism and may increase blood sugar levels when enough medication enters the bloodstream.

However, Nasacort AQ is administered locally into the nose, and systemic absorption is relatively limited.

For most patients, properly used intranasal corticosteroids are unlikely to cause major changes in blood glucose.

The risk may be higher in patients who use excessive doses, require prolonged treatment, or take additional systemic corticosteroids.

Patients with diabetes should continue following their usual blood glucose monitoring and treatment plans.

If you notice consistently higher blood sugar readings after starting Nasacort AQ, contact your healthcare provider.

Symptoms of elevated blood glucose may include increased thirst, frequent urination, unusual fatigue, and blurred vision.

Tell your healthcare provider if you have diabetes. Continue monitoring your blood glucose as directed, especially if you use other corticosteroid medications or notice unexplained increases in your readings.

Pregnancy and Nasacort AQ

Consult your healthcare provider before using Nasacort AQ if you are pregnant, planning to become pregnant, or think you may be pregnant.

There is limited information about the safety of triamcinolone acetonide nasal spray during human pregnancy.

Although Nasacort AQ acts primarily in the nasal passages, a small amount of the medication may be absorbed into the bloodstream.

Animal studies involving triamcinolone have identified potential developmental effects at certain exposures.

However, animal study findings do not necessarily predict the risks associated with recommended intranasal doses in humans.

The Canadian Nasacort AQ product monograph states that its safety during pregnancy has not been established.

Your healthcare provider will consider the severity of your allergy symptoms, your medical history, and the potential benefits and risks of treatment.

If medication is needed during pregnancy, your healthcare provider may recommend a nasal corticosteroid with more established pregnancy safety information.

Do not assume that all nasal allergy sprays are equally appropriate during pregnancy.

Use Nasacort AQ during pregnancy only when your healthcare provider determines that the expected benefits outweigh the potential risks. 

Breastfeeding and Nasacort AQ

Tell your healthcare provider if you are breastfeeding before starting Nasacort AQ.

It is not known whether triamcinolone acetonide from Nasacort AQ passes into human breast milk in clinically significant amounts.

However, corticosteroids as a class can enter breast milk, depending on the medication, dosage, and route of administration.

Because Nasacort AQ is administered into the nose and systemic absorption is relatively limited, exposure to a breastfed infant is expected to be low when the medication is used correctly.

Nevertheless, information specific to Nasacort AQ during breastfeeding remains limited.

Your healthcare provider will consider the benefits of breastfeeding, your treatment needs, and any potential risks to your baby.

Consult your healthcare provider before using Nasacort AQ while breastfeeding, and follow the lowest effective prescribed dosage. 

Growth Monitoring in Children

Children receiving Nasacort AQ for extended periods may require regular growth monitoring.

Corticosteroids can affect growth in some children, even when administered through the nose.

Clinical studies have reported reduced growth velocity in certain children using intranasal corticosteroids.

Growth velocity refers to how quickly a child increases in height over time.

A reduction in growth velocity does not necessarily mean that a child will permanently have a shorter adult height.

However, the long-term effects are not fully established.

Parents and caregivers should use only the recommended pediatric dosage and avoid increasing the number of sprays without medical guidance.

Your healthcare provider may periodically measure your child’s height and review whether treatment is still necessary.

Children should use Nasacort AQ at the lowest effective dose appropriate for their age, with growth monitored during prolonged treatment. 

Important Safety Reminders When Using Nasacort AQ

Nasacort AQ is a corticosteroid nasal spray used to relieve symptoms of seasonal and perennial allergic rhinitis.

Although it is generally well tolerated when used correctly, certain medical conditions may require additional precautions.

Patients with active infections, recent nasal surgery, glaucoma, cataracts, or a history of ocular herpes should discuss these conditions with their healthcare provider.

Prolonged use or excessive doses may increase the risk of systemic corticosteroid effects, including adrenal suppression.

Patients who take other corticosteroids should have their overall medication exposure reviewed.

Pregnant or breastfeeding patients should also consult their healthcare provider before starting treatment.

Use Nasacort AQ only as directed, avoid exceeding the recommended dosage, and seek medical advice if you develop frequent nosebleeds, changes in vision, signs of infection, or unusual systemic symptoms.

Can Nasacort AQ Nasal Spray Be Used by Children?

Yes. Nasacort AQ may be prescribed to children when a healthcare provider determines that treatment is appropriate for their age and allergy symptoms. Nasacort AQ contains triamcinolone acetonide, a corticosteroid that helps reduce inflammation inside the nasal passages. It is used to relieve symptoms of allergic rhinitis, including nasal congestion, sneezing, and a runny or itchy nose. In Canada, prescription Nasacort AQ is indicated for children aged 4 to 12 years whose seasonal or perennial allergic rhinitis has not responded adequately to conventional treatment. Children younger than four years should not use Canadian prescription Nasacort AQ because there is insufficient clinical information about its safety and effectiveness in this age group. The separate nonprescription Nasacort Allergy 24HR product is intended for adults and children aged 12 years and older in Canada. The approved age ranges may differ in other countries. Children may require assistance from a parent or caregiver to administer the nasal spray correctly. Because prolonged use of nasal corticosteroids may affect growth in some children, healthcare providers may recommend regular height monitoring during extended treatment. Nasacort AQ may be used in eligible children under medical supervision. Always follow the age restrictions and dosage instructions for the specific Nasacort product being used. 

Can Nasacort AQ Nasal Spray Be Used During Pregnancy or While Breastfeeding?

Consult your healthcare provider before using Nasacort AQ if you are pregnant, planning to become pregnant, or breastfeeding. Nasacort AQ contains triamcinolone acetonide, a corticosteroid that reduces inflammation and helps control nasal allergy symptoms. Although the medication is administered directly into the nose, a small amount may enter the bloodstream. There is limited information about the safety of Nasacort AQ during pregnancy. Animal studies involving triamcinolone have identified potential developmental risks at certain exposure levels, but these findings do not necessarily predict the effects of recommended nasal doses in humans. Your healthcare provider will consider the severity of your allergy symptoms and weigh the potential benefits and risks before recommending treatment. If medication is necessary, they may suggest an alternative nasal corticosteroid with more established pregnancy safety information. For breastfeeding mothers, it is not known whether triamcinolone from Nasacort AQ passes into human breast milk in clinically significant amounts. However, because only a small amount of the medication is generally absorbed into the bloodstream, exposure to a breastfed infant is expected to be low when the nasal spray is used as directed. Your healthcare provider will assess your treatment needs, your baby’s health, and any potential risks before recommending continued use. Use Nasacort AQ during pregnancy or breastfeeding only after discussing the potential benefits and risks with your healthcare provider.

What Should I Do If I Miss a Dose of Nasacort AQ Nasal Spray?

If you forget to use Nasacort AQ, administer the missed dose when you remember, unless it is almost time for your next scheduled dose. If your next dose is approaching, skip the missed dose and continue with your regular treatment schedule. Do not use additional sprays to make up for a missed application. Using more Nasacort AQ than recommended may increase the likelihood of side effects without providing better allergy relief. Nasacort AQ works by gradually reducing inflammation in the nasal passages. For this reason, consistent use is important for managing ongoing allergy symptoms. Some patients may notice improvements within the first day, while others require several days of regular treatment. To help remember your medication, consider using a phone reminder or incorporating the nasal spray into your daily routine. If you frequently miss doses, consult your healthcare provider or pharmacist for advice. Never double your Nasacort AQ dose to make up for a missed application. Continue using the medication according to your prescribed schedule.

Can Nasacort AQ Nasal Spray Be Used With Other Medications?

Nasacort AQ may be used alongside certain medications, but you should tell your healthcare provider about all prescription drugs, over-the-counter products, vitamins, and herbal supplements you take. Although Nasacort AQ acts mainly inside the nasal passages, some triamcinolone may enter the bloodstream. Certain medications may increase systemic corticosteroid exposure or the likelihood of side effects. For example, patients who use other corticosteroids, such as prednisone tablets, asthma inhalers, or medicated skin creams, may have greater overall corticosteroid exposure. Combining multiple corticosteroid treatments may increase the risk of side effects, particularly when used at high doses or for extended periods. Some medications that strongly inhibit the CYP3A4 enzyme, including certain antifungal and antiviral treatments, may also increase corticosteroid exposure. Patients receiving immunosuppressive medications may require additional precautions because these treatments can affect the body’s ability to fight infections. However, not every medication interaction is clinically significant, and some allergy treatments can be used together when recommended by a healthcare provider. Your healthcare provider or pharmacist can review your medication list and determine whether additional monitoring is necessary. Tell your healthcare provider about all medications and supplements you take before starting Nasacort AQ. Do not combine corticosteroid treatments or change prescribed medications without medical advice. 

How Should I Store Nasacort AQ Nasal Spray?

Nasacort AQ should be stored at room temperature, generally between 20°C and 25°C (68°F and 77°F), according to the product’s storage instructions. Keep the spray bottle in its original packaging and protect it from excessive heat and freezing temperatures. Avoid storing Nasacort AQ in areas exposed to direct sunlight or significant temperature changes. Bathrooms, vehicles, and locations near heating appliances may not provide suitable storage conditions. Replace the protective cap after each use to help keep the spray nozzle clean. Do not share the nasal spray with another person because this may spread infections. 

When Should I Discard the Bottle?

Certain Nasacort AQ bottles contain 120 metered sprays. Once the labeled number of sprays has been used, the bottle may no longer deliver an accurate amount of medication. Even if liquid remains inside the container, the medication may not be dispensed at the correct dosage. Canadian prescription Nasacort AQ instructions also recommend discarding the bottle after two months of use or after 120 sprays, whichever occurs first. The exact discard instructions may differ between products and package sizes. Do not transfer remaining medication into another container or attempt to refill the bottle. Keep Nasacort AQ out of the sight and reach of children and pets. If the medication has expired or is no longer needed, ask your pharmacist about proper disposal. Store Nasacort AQ at room temperature; do not freeze it, and discard the spray bottle according to the manufacturer’s instructions, even if medication remains inside. 

REVIEWS

Additional Information Book
Generic name:

Triamcinolone Acetonide

Formulation:

Nasal spray

Strength(s):

55ug

Quantities Available:

120doses, 360doses

Why customers love Online Pharmacies Canada

Our online Canadian Pharmacy is known for high standards of quality, safety, and efficiency when it comes to medications.

Our pharmacy offers lower prices on prescription drugs compared to traditional pharmacies.

How to Order

How much Nasacort AQ Nasal Spray can I order at once from a Canadian pharmacy?

When ordering Nasacort AQ Nasal Spray (triamcinolone acetonide) from a Canadian pharmacy, you can typically purchase up to a 90-day supply at one time, which is common for prescription medications to ensure adequate management of chronic conditions without frequent refills.

Here’s what you need to know:

Dosage and Quantity: Nasacort AQ Nasal Spray is commonly prescribed with a dosage of 55 mcg per spray, with the usual dosing of 1 to 2 sprays in each nostril once daily. For a 90-day supply, considering the maximum daily dose of 2 sprays per nostril (4 sprays per day), you would order up to 360 sprays (90 days x 4 sprays per day).

Do you sell triamcinolone acetonide?

No, we do not sell triamcinolone acetonide. However, you can still enjoy low prices on Nasacort AQ Nasal Spray, which contains triamcinolone acetonide as an active ingredient. You will need a valid prescription from your healthcare provider to purchase this medication. We require this to dispense the medication safely and accurately. You can mail, fax, or upload your prescription through your online account for your convenience.

Do you offer shipping of Nasacort AQ Nasal Spray (triamcinolone acetonide) to the United States?

Yes, we ship Nasacort AQ Nasal Spray (triamcinolone acetonide) to both the United States and Puerto Rico.

Discover Our Users' Stories!

Watch how Online Pharmacies Canada is helping customers save money on their medications.

Online Pharmacies Canada Customer Testimonial #4
Online Pharmacies Canada Customer Testimonial #1
Online Pharmacies Canada - Customer Testimonial #2

Online Pharmacies Canada has provided information from third parties intended to increase awareness and does not contain all the information about Nasacort AQ Nasal Spray (Triamcinolone Acetonide). Talk to your doctor or other qualified medical practitioners for medical attention or advice, or if you have any concerns about Nasacort AQ Nasal Spray (Triamcinolone Acetonide).